Advances in Brief Elimination of Colon Cancer in Germ-free Transforming Growth Factor Beta 1-deficient Mice 1
暂无分享,去创建一个
S. Pawlowski | G. Boivin | T. Doetschman | S. Engle | I. Ormsby | E. Balish | J. Croft
[1] G. Boivin,et al. Germ-free and barrier-raised TGFβ1-deficient mice have similar inflammatory lesions , 1997, Transgenic Research.
[2] Kan Yang,et al. Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2 , 2002, Science.
[3] R. Hershberg,et al. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[4] Samir A. Shah,et al. Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and beta(2)-microglobulin-deficient mouse. , 2001, Cancer research.
[5] J. Gordon,et al. Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.
[6] S. Markowitz,et al. Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis , 2000 .
[7] M. Bronner,et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. , 1999, Cancer research.
[8] P S Gartside,et al. Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. , 1999, Cancer research.
[9] K. Kinzler,et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. , 1999, Cancer research.
[10] J. Graff,et al. Smad3 Mutant Mice Develop Metastatic Colorectal Cancer , 1998, Cell.
[11] K. Do,et al. Morphology of sporadic colorectal cancer with DNA replication errors , 1998, Gut.
[12] K. Chawengsaksophak,et al. Homeosis and intestinal tumours in Cdx2 mutant mice , 1997, Nature.
[13] A. Moser,et al. Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. , 1997, Cancer research.
[14] M. Yin,et al. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] K. Kinzler,et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. , 1995, Cancer research.
[16] J. Mudgett,et al. A Natural Disruption of the Secretory Group II Phospholipase A2 Gene in Inbred Mouse Strains (*) , 1995, The Journal of Biological Chemistry.
[17] K. Kinzler,et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.
[18] C. Elson,et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. , 1994, Gastroenterology.
[19] G. Proetzel,et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.
[20] A. Manning,et al. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. , 1991, Oncogene.
[21] H. Filutowicz,et al. Serum antibody response of gnotobiotic athymic and euthymic mice following alimentary tract colonization and infection with Candida albicans. , 1991, Canadian journal of microbiology.